AI Scribes — Medical Device Classification and UK Regulatory Determination
OVERVIEWRegulatory bodies are debating whether AI scribes qualify as medical devices requiring formal authorization and oversight. The UK's regulatory determination that AI scribes are NOT medical devices contrasts with potential FDA classification, creating international regulatory divergence. Regulatory Positions: - UK MHRA: AI scribes do not qualify as medical devices because they don't directly diagnose or treat patients; they document clinician observations - FDA (Emerging): Considering whether ambient AI documentation tools require 510(k) clearance or other oversight - State Boards: Medical boards lack clear guidance on AI scribe liability and physician responsibility Classification Implications: If AI scribes are classified as medical devices, they require FDA clearance before deployment. This would slow adoption but potentially improve quality and safety standards. If not classified as devices, AI scribes remain largely unregulated. Clinical Risk Perspective: Even if not classified as medical devices, AI scribes generate medical records that serve as clinical and legal evidence. Poor documentation quality can harm patients and create liability regardless of regulatory classification. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.